-+ 0.00%
-+ 0.00%
-+ 0.00%

ACLARIS THERAPEUTICS, INC.: EXPECTS TO INITIATE A PHASED MULTI-PART PHASE 2B TRIAL OF MODZATINIB IN LP IN Q4 OF 2026

Reuters·08/06/2026 20:35:00

Please log in to view news